| __timestamp | Agios Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 12402000000 |
| Thursday, January 1, 2015 | 141827000 | 17449000000 |
| Friday, January 1, 2016 | 220163000 | 17834000000 |
| Sunday, January 1, 2017 | 292681000 | 19551000000 |
| Monday, January 1, 2018 | 341324000 | 18265000000 |
| Tuesday, January 1, 2019 | 410894000 | 15607000000 |
| Wednesday, January 1, 2020 | 367470000 | 15410000000 |
| Friday, January 1, 2021 | 256973000 | 16541000000 |
| Saturday, January 1, 2022 | 279910000 | 17482000000 |
| Sunday, January 1, 2023 | 288903000 | 19381000000 |
| Monday, January 1, 2024 | 301286000 | 22873000000 |
Data in motion
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) budgets are a critical indicator of a company's commitment to innovation. Over the past decade, Dr. Reddy's Laboratories Limited and Agios Pharmaceuticals, Inc. have showcased contrasting R&D investment strategies. Dr. Reddy's, a stalwart in the industry, consistently allocated substantial resources, with R&D expenses peaking at nearly $19.4 billion in 2023, reflecting a steady growth of approximately 56% since 2014. In contrast, Agios Pharmaceuticals, a relatively newer player, demonstrated a more volatile yet ambitious approach, with R&D spending reaching its zenith in 2019 at around $411 million, marking a 310% increase from 2014. However, Agios's data for 2024 remains elusive, hinting at potential strategic shifts. This analysis underscores the diverse paths companies take in their quest for pharmaceutical breakthroughs, each with its unique challenges and opportunities.
Comparing Innovation Spending: AstraZeneca PLC and Dr. Reddy's Laboratories Limited
Regeneron Pharmaceuticals, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited
R&D Insights: How Dr. Reddy's Laboratories Limited and Exelixis, Inc. Allocate Funds
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Alkermes plc
Dr. Reddy's Laboratories Limited or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development Investment: Dr. Reddy's Laboratories Limited vs MiMedx Group, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Protagonist Therapeutics, Inc. and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and Xencor, Inc.